Logo image of U-U.CA

SPROTT PHYSICAL URANIUM TR (U-U.CA) Stock Price, Quote, News and Overview

TSX:U-U - Toronto Stock Exchange - CA85210A1049 - Currency: USD

16.42  +0.05 (+0.31%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to U-U. U-U was compared to 79 industry peers in the Capital Markets industry. While U-U has a great health rating, there are worries on its profitability. U-U is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

U-U had negative earnings in the past year.
In the past year U-U has reported a negative cash flow from operations.
In multiple years U-U reported negative net income over the last 5 years.
In the past 5 years U-U always reported negative operating cash flow.
U-U.CA Yearly Net Income VS EBIT VS OCF VS FCFU-U.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

U-U has a Return On Assets of -25.07%. This is amonst the worse of the industry: U-U underperforms 87.34% of its industry peers.
U-U has a worse Return On Equity (-25.10%) than 83.54% of its industry peers.
Industry RankSector Rank
ROA -25.07%
ROE -25.1%
ROIC N/A
ROA(3y)8.92%
ROA(5y)4.61%
ROE(3y)8.98%
ROE(5y)4.64%
ROIC(3y)N/A
ROIC(5y)N/A
U-U.CA Yearly ROA, ROE, ROICU-U.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

In the last couple of years the Profit Margin of U-U has remained more or less at the same level.
U-U's Operating Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for U-U so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y6.22%
OM growth 5Y1.36%
PM growth 3Y6.55%
PM growth 5Y1.15%
GM growth 3YN/A
GM growth 5YN/A
U-U.CA Yearly Profit, Operating, Gross MarginsU-U.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, U-U has more shares outstanding
The number of shares outstanding for U-U has been increased compared to 5 years ago.
U-U has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
U-U.CA Yearly Shares OutstandingU-U.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
U-U.CA Yearly Total Debt VS Total AssetsU-U.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

U-U has an Altman-Z score of 339.20. This indicates that U-U is financially healthy and has little risk of bankruptcy at the moment.
U-U has a Altman-Z score of 339.20. This is amongst the best in the industry. U-U outperforms 98.73% of its industry peers.
There is no outstanding debt for U-U. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 339.2
ROIC/WACCN/A
WACCN/A
U-U.CA Yearly LT Debt VS Equity VS FCFU-U.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

U-U has a Current Ratio of 3.74. This indicates that U-U is financially healthy and has no problem in meeting its short term obligations.
U-U has a better Current ratio (3.74) than 77.22% of its industry peers.
U-U has a Quick Ratio of 3.74. This indicates that U-U is financially healthy and has no problem in meeting its short term obligations.
U-U has a better Quick ratio (3.74) than 77.22% of its industry peers.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 3.74
U-U.CA Yearly Current Assets VS Current LiabilitesU-U.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for U-U have decreased strongly by -143.70% in the last year.
U-U shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -144.42%.
EPS 1Y (TTM)-143.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.44%
Revenue 1Y (TTM)-144.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-136.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
U-U.CA Yearly Revenue VS EstimatesU-U.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
U-U.CA Yearly EPS VS EstimatesU-U.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 0 0.5 -0.5 1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

U-U reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
U-U.CA Price Earnings VS Forward Price EarningsU-U.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
U-U.CA Per share dataU-U.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

U-U does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPROTT PHYSICAL URANIUM TR

TSX:U-U (8/11/2025, 7:00:00 PM)

16.42

+0.05 (+0.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-25 2025-03-25
Earnings (Next)08-14 2025-08-14
Inst Owners18.35%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.65B
Analysts82.5
Price Target19.76 (20.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.91%
PT rev (3m)-17.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)-6.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS-5.75
BVpS23.65
TBVpS23.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.07%
ROE -25.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)8.92%
ROA(5y)4.61%
ROE(3y)8.98%
ROE(5y)4.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y6.22%
OM growth 5Y1.36%
PM growth 3Y6.55%
PM growth 5Y1.15%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover-0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 3.74
Altman-Z 339.2
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-143.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-135.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-144.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-136.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-146.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-124.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.04%
OCF growth 3YN/A
OCF growth 5YN/A